Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient

被引:15
作者
Arnold, DS [1 ]
Rosse, RB
Dickinson, D
Benham, R
Deutsch, SI
Nelson, MW
机构
[1] Dept Vet Med, VISN Mental Hlth Serv Line 5, Linthicum, MD USA
[2] Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
关键词
D O I
10.4088/JCP.v65n1219e
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:1723 / 1724
页数:2
相关论文
共 9 条
[1]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[2]  
Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117
[3]   Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia [J].
Breese, CR ;
Lee, MJ ;
Adams, CE ;
Sullivan, B ;
Logel, J ;
Gillen, KM ;
Marks, MJ ;
Collins, AC ;
Leonard, S .
NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) :351-364
[4]   Cholinesterase inhibitors: A new class of psychotropic compounds [J].
Cummings, JL .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :4-15
[5]   Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia [J].
Leonard, S ;
Gault, J ;
Hopkins, J ;
Logel, J ;
Vianzon, R ;
Short, M ;
Drebing, C ;
Berger, R ;
Venn, D ;
Sirota, P ;
Zerbe, G ;
Olincy, A ;
Ross, RG ;
Adler, LE ;
Freedman, R .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (12) :1085-1096
[6]   RELIABILITY AND VALIDITY OF THE APATHY EVALUATION SCALE [J].
MARIN, RS ;
BIEDRZYCKI, RC ;
FIRINCIOGULLARI, S .
PSYCHIATRY RESEARCH, 1991, 38 (02) :143-162
[7]   Galantamine in AD - A 6-month randomized, placebo-controlled trial with a 6-month extension [J].
Raskind, MA ;
Peskind, ER ;
Wessel, T ;
Yuan, W .
NEUROLOGY, 2000, 54 (12) :2261-2268
[8]   Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia [J].
Rosse, RB ;
Deutsch, SI .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (05) :272-275
[9]   A 5-month, randomized, placebo-controlled trial of galantamine in AD [J].
Tariot, PN ;
Solomon, PR ;
Morris, JC ;
Kershaw, P ;
Lilienfeld, S ;
Ding, C .
NEUROLOGY, 2000, 54 (12) :2269-2276